FDA Approves Two Versions of Generic Glucophage

The FDA has granted final approval to Andrx and Alpharma to market generic versions of Bristol-Myers Squibb's diabetes drug Glucophage (metformin HCl).

Both companies were cleared to begin selling metformin HCl extended-release 750-mg tablets. Andrx said it has already commenced shipments of the product. Alpharma said it will launch its product immediately.